a unique new oral contraceptive called Yasmin
February 2005
Health Canada has approved a unique new oral contraceptive called Yasmin.
It contains 30 mcg of ethinyl estradiol...plus a different progestin called drospirenone.
Drospirenone is a spironolactone analogue that has anti-androgenic AND antimineralocorticoid activity.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive